These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27104018)

  • 1. The 2015 Clinical Guidelines for the Treatment and Prevention of Opportunistic Infections in HIV-Infected Koreans: Guidelines for Opportunistic Infections.
    Korean Society for AIDS
    Infect Chemother; 2016 Mar; 48(1):54-60. PubMed ID: 27104018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2015 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans.
    Korean Society for AIDS
    Infect Chemother; 2015 Sep; 47(3):205-11. PubMed ID: 26483998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2013 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans.
    Korean Society for AIDS
    Infect Chemother; 2013 Dec; 45(4):455-61. PubMed ID: 24475362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of 2021 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-infected Koreans.
    Korean Society for AIDS
    Infect Chemother; 2021 Sep; 53(3):592-616. PubMed ID: 34405598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2018 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans.
    Korean Society for AIDS
    Infect Chemother; 2019 Mar; 51(1):77-88. PubMed ID: 30941943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
    Masur H; Kaplan JE; Holmes KK; ;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):435-78. PubMed ID: 12617574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
    Kaplan JE; Masur H; Holmes KK; ;
    MMWR Recomm Rep; 2002 Jun; 51(RR-8):1-52. PubMed ID: 12081007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.
    Mofenson LM; Oleske J; Serchuck L; Van Dyke R; Wilfert C; ; ;
    MMWR Recomm Rep; 2004 Dec; 53(RR-14):1-92. PubMed ID: 15577752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM
    Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of Guidelines for the Use of Pre-Exposure Prophylaxis for HIV in Korea.
    Korean Society for AIDS
    Infect Chemother; 2017 Sep; 49(3):243-246. PubMed ID: 29027392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis, treatment, and prevention of selected common HIV-related opportunistic infections in the Caribbean region.
    Kaplan JE
    Top HIV Med; 2004 Dec-2005 Jan; 12(5):136-41. PubMed ID: 15647609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
    Moore RD; Chaisson RE
    Ann Intern Med; 1996 Apr; 124(7):633-42. PubMed ID: 8607591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.
    Mofenson LM; Oleske J; Serchuck L; Van Dyke R; Wilfert C
    Clin Infect Dis; 2005 Feb; 40 Suppl 1():S1-84. PubMed ID: 15655768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1995 Apr; 44(RR-4):1-11. PubMed ID: 7565543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics and T-lymphocyte subsets in 48 acquired immune deficiency syndrome patients with cytomegalovirus infections].
    Jia CH; Wang L; Jing FH; Xie J; Qiu ZF; Li TS; Lyu W
    Zhonghua Nei Ke Za Zhi; 2019 Mar; 58(3):191-197. PubMed ID: 30803177
    [No Abstract]   [Full Text] [Related]  

  • 16. Discontinuation of highly active antiretroviral therapy leads to cryptococcal meningitis/choroiditis in an AIDS patient.
    Chronister CL
    Optometry; 2006 Sep; 77(9):438-45. PubMed ID: 16939885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts.
    Yazdanpanah Y; Chêne G; Losina E; Goldie SJ; Merchadou LD; Alfandari S; Seage GR; Sullivan L; Marimoutou C; Paltiel AD; Salamon R; Mouton Y; Freedberg KA
    Int J Epidemiol; 2001 Aug; 30(4):864-71. PubMed ID: 11511618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunistic infections in AIDS in developed and developing countries.
    Fleming AF
    Trans R Soc Trop Med Hyg; 1990; 84 Suppl 1():1-6. PubMed ID: 2201107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of human immunodeficiency virus-associated cryptococcal meningitis: Current status and future directions.
    Wu X; Shen Y
    Mycoses; 2019 Oct; 62(10):874-882. PubMed ID: 31365770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.